Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response

Detalhes bibliográficos
Autor(a) principal: Bittencourt, Najara Carneiro
Data de Publicação: 2020
Outros Autores: Silva, Ana Beatriz Iung Enembreck da, Virgili, Natália Silveira, Schappo, Ana Paula, Gervásio, João Henrique D. B., Pimenta, Tamirys S., Kujbida Junior, Mario A., Ventura, Ana Maria R. S., Libonati, Rosana M. F., Silva-Filho, João Luiz, Santos, Hellen Geremias dos, Lopes, Stefanie C. P., Lacerda, Marcus V. G., Machado, Ricardo L. D., Costa, Fabio T. M., Albrecht, Letusa
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/42874
Resumo: Universidade Estadual de Campinas. Instituto de Biologia. Departamento de Genética, Evolução, Microbiologia e Imunologia. Campinas, SP, Brasil.
id CRUZ_13b9ed41d07e7934020ffd77080140f3
oai_identifier_str oai:www.arca.fiocruz.br:icict/42874
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Bittencourt, Najara CarneiroSilva, Ana Beatriz Iung Enembreck daVirgili, Natália SilveiraSchappo, Ana PaulaGervásio, João Henrique D. B.Pimenta, Tamirys S.Kujbida Junior, Mario A.Ventura, Ana Maria R. S.Libonati, Rosana M. F.Silva-Filho, João LuizSantos, Hellen Geremias dosLopes, Stefanie C. P.Lacerda, Marcus V. G.Machado, Ricardo L. D.Costa, Fabio T. M.Albrecht, Letusa2020-08-21T20:50:56Z2020-08-21T20:50:56Z2020BITTENCOURT, Najara Carneiro et al. Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response. PLoS Negl Trop Dis., v. 14, n. 7, p. 1-21, 2020.1935-2735https://www.arca.fiocruz.br/handle/icict/4287410.1371/journal.pntd.00084711935-2735porPublic Library of SciencePlasmodium vivaxAMA1Malaria, VivaxDrug ResistanceVaccinesAntigensMalaria VivaxResistencia a MedicamentosVacunasAntígenosPaludisme à Plasmodium vivaxRésistance aux substancesVaccinsAntigènesMalária VivaxResistência a MedicamentosVacinasAntígenosPlasmodium vivax AMA1: Implications of distinct haplotypes for immune responseinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Estadual de Campinas. Instituto de Biologia. Departamento de Genética, Evolução, Microbiologia e Imunologia. Campinas, SP, Brasil.Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.Universidade Estadual de Campinas. Instituto de Biologia. Departamento de Genética, Evolução, Microbiologia e Imunologia. Campinas, SP, Brasil.Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.Universidade Federal do Pará. Núcleo de Medicina Tropical. Belém, PA, Brasil.Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.Universidade Federal do Pará. Núcleo de Medicina Tropical. Belém, PA, Brasil.Universidade Federal do Pará. Núcleo de Medicina Tropical. Belém, PA, Brasil.Universidade Estadual de Campinas. Instituto de Biologia. Departamento de Genética, Evolução, Microbiologia e Imunologia. Campinas, SP, Brasil.Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Gerência de Malária. Manaus, AM, Brasil. / Fundação Oswaldo Cruz. Instituto Leônidas & Maria Deane. Manaus, AM, Brasil.Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Gerência de Malária. Manaus, AM, Brasil. / Fundação Oswaldo Cruz. Instituto Leônidas & Maria Deane. Manaus, AM, Brasil.Universidade Federal Fluminense. Centro de Investigação de Microrganismos. Niterói, RJ, Brasil.Universidade Estadual de Campinas. Instituto de Biologia. Departamento de Genética, Evolução, Microbiologia e Imunologia. Campinas, SP, Brasil.Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil.In Brazil, Plasmodium vivax infection accounts for around 80% of malaria cases. This infection has a substantial impact on the productivity of the local population as the course of the disease is usually prolonged and the development of acquired immunity in endemic areas takes several years. The recent emergence of drug-resistant strains has intensified research on alternative control methods such as vaccines. There is currently no effective available vaccine against malaria; however, numerous candidates have been studied in the past several years. One of the leading candidates is apical membrane antigen 1 (AMA1). This protein is involved in the invasion of Apicomplexa parasites into host cells, participating in the formation of a moving junction. Understanding how the genetic diversity of an antigen influences the immune response is highly important for vaccine development. In this study, we analyzed the diversity of AMA1 from Brazilian P. vivax isolates and 19 haplotypes of P. vivax were found. Among those sequences, 33 nonsynonymous PvAMA1 amino acid sites were identified, whereas 20 of these sites were determined to be located in predicted B-cell epitopes. Nonsynonymous mutations were evaluated for their influence on the immune recognition of these antigens. Two distinct haplotypes, 5 and 16, were expressed and evaluated for reactivity in individuals from northern Brazil. Both PvAMA1 variants were reactive. Moreover, the IgG antibody response to these two PvAMA1 variants was analyzed in an exposed but noninfected population from a P. vivax endemic area. Interestingly, over 40% of this population had antibodies recognizing both variants. These results have implications for the design of a vaccine based on a polymorphic antigen.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83084https://www.arca.fiocruz.br/bitstream/icict/42874/1/license.txt783568c2893d2e25a99990b126be1772MD51ORIGINALpntd.0008471ok.pdfpntd.0008471ok.pdfapplication/pdf2290399https://www.arca.fiocruz.br/bitstream/icict/42874/2/pntd.0008471ok.pdfa3a645c40206f3cdfc489edf589ed8efMD52TEXTpntd.0008471ok.pdf.txtpntd.0008471ok.pdf.txtExtracted texttext/plain69165https://www.arca.fiocruz.br/bitstream/icict/42874/3/pntd.0008471ok.pdf.txt934934d74721536e55c0fa96e1866b33MD53icict/428742020-08-22 02:04:15.186oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352020-08-22T05:04:15Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response
title Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response
spellingShingle Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response
Bittencourt, Najara Carneiro
Plasmodium vivax
AMA1
Malaria, Vivax
Drug Resistance
Vaccines
Antigens
Malaria Vivax
Resistencia a Medicamentos
Vacunas
Antígenos
Paludisme à Plasmodium vivax
Résistance aux substances
Vaccins
Antigènes
Malária Vivax
Resistência a Medicamentos
Vacinas
Antígenos
title_short Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response
title_full Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response
title_fullStr Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response
title_full_unstemmed Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response
title_sort Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response
author Bittencourt, Najara Carneiro
author_facet Bittencourt, Najara Carneiro
Silva, Ana Beatriz Iung Enembreck da
Virgili, Natália Silveira
Schappo, Ana Paula
Gervásio, João Henrique D. B.
Pimenta, Tamirys S.
Kujbida Junior, Mario A.
Ventura, Ana Maria R. S.
Libonati, Rosana M. F.
Silva-Filho, João Luiz
Santos, Hellen Geremias dos
Lopes, Stefanie C. P.
Lacerda, Marcus V. G.
Machado, Ricardo L. D.
Costa, Fabio T. M.
Albrecht, Letusa
author_role author
author2 Silva, Ana Beatriz Iung Enembreck da
Virgili, Natália Silveira
Schappo, Ana Paula
Gervásio, João Henrique D. B.
Pimenta, Tamirys S.
Kujbida Junior, Mario A.
Ventura, Ana Maria R. S.
Libonati, Rosana M. F.
Silva-Filho, João Luiz
Santos, Hellen Geremias dos
Lopes, Stefanie C. P.
Lacerda, Marcus V. G.
Machado, Ricardo L. D.
Costa, Fabio T. M.
Albrecht, Letusa
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Bittencourt, Najara Carneiro
Silva, Ana Beatriz Iung Enembreck da
Virgili, Natália Silveira
Schappo, Ana Paula
Gervásio, João Henrique D. B.
Pimenta, Tamirys S.
Kujbida Junior, Mario A.
Ventura, Ana Maria R. S.
Libonati, Rosana M. F.
Silva-Filho, João Luiz
Santos, Hellen Geremias dos
Lopes, Stefanie C. P.
Lacerda, Marcus V. G.
Machado, Ricardo L. D.
Costa, Fabio T. M.
Albrecht, Letusa
dc.subject.other.pt_BR.fl_str_mv Plasmodium vivax
AMA1
topic Plasmodium vivax
AMA1
Malaria, Vivax
Drug Resistance
Vaccines
Antigens
Malaria Vivax
Resistencia a Medicamentos
Vacunas
Antígenos
Paludisme à Plasmodium vivax
Résistance aux substances
Vaccins
Antigènes
Malária Vivax
Resistência a Medicamentos
Vacinas
Antígenos
dc.subject.en.pt_BR.fl_str_mv Malaria, Vivax
Drug Resistance
Vaccines
Antigens
dc.subject.es.pt_BR.fl_str_mv Malaria Vivax
Resistencia a Medicamentos
Vacunas
Antígenos
dc.subject.fr.pt_BR.fl_str_mv Paludisme à Plasmodium vivax
Résistance aux substances
Vaccins
Antigènes
dc.subject.decs.pt_BR.fl_str_mv Malária Vivax
Resistência a Medicamentos
Vacinas
Antígenos
description Universidade Estadual de Campinas. Instituto de Biologia. Departamento de Genética, Evolução, Microbiologia e Imunologia. Campinas, SP, Brasil.
publishDate 2020
dc.date.accessioned.fl_str_mv 2020-08-21T20:50:56Z
dc.date.available.fl_str_mv 2020-08-21T20:50:56Z
dc.date.issued.fl_str_mv 2020
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv BITTENCOURT, Najara Carneiro et al. Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response. PLoS Negl Trop Dis., v. 14, n. 7, p. 1-21, 2020.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/42874
dc.identifier.issn.pt_BR.fl_str_mv 1935-2735
dc.identifier.doi.none.fl_str_mv 10.1371/journal.pntd.0008471
dc.identifier.eissn.none.fl_str_mv 1935-2735
identifier_str_mv BITTENCOURT, Najara Carneiro et al. Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response. PLoS Negl Trop Dis., v. 14, n. 7, p. 1-21, 2020.
1935-2735
10.1371/journal.pntd.0008471
url https://www.arca.fiocruz.br/handle/icict/42874
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Public Library of Science
publisher.none.fl_str_mv Public Library of Science
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/42874/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/42874/2/pntd.0008471ok.pdf
https://www.arca.fiocruz.br/bitstream/icict/42874/3/pntd.0008471ok.pdf.txt
bitstream.checksum.fl_str_mv 783568c2893d2e25a99990b126be1772
a3a645c40206f3cdfc489edf589ed8ef
934934d74721536e55c0fa96e1866b33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324828085682176